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AGREEMENT BETWEEN MAGNETIC RESONANCE IMAGING
AND ULTRASONOGRAPHY IN THE CLASSIFICATION
OF SCHISTOSOMAL PERIPORTAL FIBROSIS, ACCORDING
TO NIAMEY’S CRITERIA*
Eduardo Scortegagna Junior1, Alberto Ribeiro de Souza Leão2, José Eduardo Mourão Santos3,
Danilo Moulin Sales1, David Carlos Shigueoka4, Luciane Aparecida Kopke de Aguiar5, Paulo
Eugênio Brant5, Ramiro Colleoni Neto6, Durval Rosa Borges7, Giuseppe D’Ippolito8
OBJECTIVE: To evaluate the reproducibility of magnetic resonance imaging and the agreement between
ultrasound and magnetic resonance imaging in the classification of periportal fibrosis in patients with schis-
tosomiasis based on Niamey’s qualitative criteria. MATERIALS AND METHODS: A prospective, double-blinded
study was conducted between February 2005 and June 2006 with 20 patients (10 men and 10 women,
with ages ranging between 24 and 60 years, mean age 42.7 years) diagnosed with schistosomiasis mansoni.
Both ultrasound and magnetic resonance images were independently evaluated by two experienced observ-
ers. Interobserver agreement was evaluated for findings of periportal fibrosis on magnetic resonance images
and in a comparison between magnetic resonance and ultrasound images. RESULTS: The analysis of mag-
netic resonance images showed total interobserver agreement in 14 patients (70%). The comparison be-
tween ultrasound and magnetic resonance imaging showed agreement between images in only six cases
(30%) by observer 1, and in eight cases (40%) by observer 2. CONCLUSION: Magnetic resonance imaging
presents a good reproducibility in the evaluation of periportal fibrosis in later stages of schistosomiasis,
however, the correlation between magnetic resonance imaging and ultrasound is poor.
Keywords: Schistosomiasis; Periportal fibrosis; Ultrasound; Magnetic resonance imaging.
Avaliação da concordância entre ressonância magnética e ultra-sonografia na classificação da fibrose peri-
portal em esquistossomóticos, segundo a classificação de Niamey.
OBJETIVO: Avaliar a reprodutibilidade da ressonância magnética e a concordância entre a ultra-sonografia
e a ressonância magnética na classificação da fibrose periportal em pacientes esquistossomóticos, segundo
os critérios qualitativos de Niamey. MATERIAIS E MÉTODOS: Foi realizado estudo prospectivo e duplo-cego,
entre fevereiro de 2005 e junho de 2006, em 20 pacientes (10 homens e 10 mulheres, idades entre 24 e 60
anos, média de 42,75 anos) com diagnóstico de esquistossomose mansônica. As imagens de ultra-sonogra-
fia e de ressonância magnética foram avaliadas por dois examinadores experientes de forma independente.
Foi medida a concordância interobservador para a ressonância magnética e entre a ressonância magnética e
a ultra-sonografia. RESULTADOS: A ressonância magnética apresentou resultados concordantes entre os
observadores em 14 pacientes (70%). Quando comparamos a ressonância magnética com a ultra-sonogra-
fia, obtivemos concordância em apenas seis pacientes pelo observador 1 (30%) e em oito pacientes pelo
observador 2 (40%). CONCLUSÃO: A ressonância magnética tem boa reprodutibilidade na avaliação de fi-
brose periportal em pacientes com esquistossomose avançada, porém sua concordância com a ultra-sono-
grafia é fraca.
Unitermos: Esquistossomose; Fibrose periportal; Ultra-sonografia; Ressonância magnética.
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problem of public health in Brazil(1,2).
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complications resulting from schistosomia-
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inflammation and occurs early in the dis-
ease progression. Periportal collagen depo-
sition leads to a progressive portal vein
occlusion, portal hypertension, and a pos-
sible progression to varices, high digestive
hemorrhage, splenomegaly and hyper-
splenism. Periportal fibrosis is characteris-
tic of the disease and may be identified by
means of several diagnostic methods(2).
Ultrasonography (US) has been the
method most frequently utilized in this
group of patients, demonstrating a typical
pattern of abnormalities(3), especially in-
cluding thickening along the walls of the
portal vein and its branches characterized
by periportal hyperechogenic bands(4).
Aiming at establishing standardized
protocol for diagnosing and quantifying
periportal fibrosis in schistosomal patients,
ultrasonographic criteria were initially de-
fined in a World Health Organization con-
sensus meeting held in Cairo in 1991(5), and
later reviewed in the meeting on “Ultra-
sound Schistosomiasis” held in 1996 in
Niamey, resulting in the evolution of the
standard ultrasound scoring protocol to
include qualitative criteria, considering the
hepatic texture as a whole, besides the pre-
vious quantitative criteria utilizing the ob-
jective measurement of the portal branch
wall thickening(4).
US, although widely adopted in the as-
sessment of patients with schistosomiasis,
has demonstrated a moderate reproducibil-
ity in the classification of portal fibrosis(6).
On the other hand, some studies have dem-
onstrated the usefulness of magnetic reso-
nance imaging (MRI) in the evaluation of
hepatosplenic and vascular alterations in
schistosomal patients, with high reproduc-
ibility(7). Additionally, the MRI capacity in
the diagnosis of hepatic fibrosis has been
well demonstrated(7).
However, the role of MRI in the char-
acterization and quantification of peripor-
tal fibrosis in schistosomal patients is still
to be established. Considering its high re-
producibility, anatomical detailing and
high spatial resolution, some authors be-
lieve that MRI may be a more sensitive
method than US for indicating the disease
progression, grading and therapeutic re-
sponse, as a result of a more comprehen-
sive evaluation of the abdominal cavity(8).
Therefore, it is important to establish the
MRI value in the evaluation of periportal
fibrosis.
The present study was aimed at evalu-
ating the MRI reproducibility and the
agreement between US and MRI in the
grading of periportal fibrosis in schistoso-
mal patients, according to qualitative cri-
teria defined in the ultrasound consensus
meeting of Niamey for assessing peripor-
tal fibrosis.
MATERIALS AND METHODS
In the period between February/2005
and June/2006, a prospective, transversal,
observational, double-blinded study was
developed with 20 patients (10 men, and 10
women in the age range between 24 and 60
years, mean 42.75 years) referred by the
clinic of schistosomiasis, Discipline of
Clinical Gastroenterology, Universidade
Federal de São Paulo/Escola Paulista de
Medicina (Unifesp/EPM), with diagnosis
of schistosomiasis mansoni. Such diagno-
sis had been obtained either by means of
rectal biopsy or consistent clinical labora-
tory (signs of portal hypertension and/or
positive fecal parasitologic examination) or
epidemiological evidence (contact with
contamined water of lakes, ponds, rivers in
endemic areas), and subclassified into the
hepatosplenic form of the disease because
of the finding of portal hypertension and
splenomegaly.
Exclusion criteria were: patients with
contraindication for MRI (cardiac pace-
maker, cochlear implants, claustrophobia,
cerebral aneurysm clips, allergy to para-
magnetic contrast agents), patients with a
previous history of alcoholism (ingestion
of more than 160 g of ethanol/week), posi-
tive serology for hepatitis B or C viruses,
with a previous history of proven autoim-
mune disease, and use of hepatotoxic
drugs.
The patients underwent US and MRI
examinations with a minimum seven-day
interval between studies. The results inter-
pretation was performed by two indepen-
dent observers, both residents in imaging
diagnosis (A.R.S.L. and D.M.S.) and with
at least two-year experience in the diagnos-
tic methods utilized, with training in ultra-
sonography specifically for assessment of
schistosomal patients. In a later moment,
the observers met to reach a consensus as
regards the sonographic classification of
periportal fibrosis which later on this study
was utilized as a gold standard in the com-
parison between readings and MRI studies.
Ultrasound scan
US scans were performed with a Philips
EnVisor® model with a convex, multi-fre-
quency, 2.5–4.5 MHz transducers, in pa-
tients after eight-hour fasting, according to
the Niamey standard protocol(4), with lon-
gitudinal (left paraesternal, right hemi-
clavicular, right anterior axillary), subster-
nal, subcostal, Intercostal left and right
oblique scans (Figure 1). The patterns ob-
served were classified according the spe-
cific protocol (Chart 1 and Figure 2).
Magnetic resonance imaging
MRI examinations were performed in a
Siemens Sonata model system operating in
a high field (1.5 T), with synergy coil and
MRI sequences configured for periportal
fibrosis assessment(9) (Chart 2).
The periportal fibrosis classification
was performed similarly to the one per-
Chart 1 Patterns of hepatic parenchyma and periportal fibrosis scores.
Reference
patterns
A
B
C
D
E
F
Periportal
fibrosis score
0
1
2
4
6
8
Image description
Normal.
Starry sky (diffuse echogenic foci).
Ring echoes and pipe stems.
Hyperechogenicity around portal bifurcation.
Hyperechoic patches extending from the portal vessels to the
parenchyma.
Hyperechoic bands extending to the hepatic parenchyma, where
they retract the organ surface.
Based on Richter et al.(4).
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Figure 1. Standard cut planes according to the
protocol established in Niamey (based on Richter
et al.(4)). Longitudinal: left parasternal (1a), right
middle-clavicular (1b), right anterior axillary (1c);
transverse substernal (2); transhepatic subcostal
(3); right oblique (4); left intercostal oblique (5).
1 2 3
4 5
Figure 2. Normal (A); “starry sky” (B); ring echoes and “pipe stems” (C); around portal bifurcation (D);
focal (E); “bird’s claw” (F): D + C combination (Dc); E + C combination (Ec). (Based on Richter et al.(4)).
Chart 2 Technical parameters utilized in the exa-
mination sequences.
Sequence
RT (ms)
ET (ms)
Flip angle (°)
No. of excitations
2D/3D
Thickness (mm)
Interval
Field-of-view
No. of slices
Orientation
Acquisition time (s)
Fase/frequency
Rectangular field-of-view
Fat saturation
Presaturation
Partial Fourier
Coil
No. of measurements/
repetitions
ECG triggering
Respiratory compensation
Order (K space coverage)
Shot
Echo train length
Bandwidth (Hz/pixel)
Apnea
T2 HASTE
800
86
180
1
2D
7
0,7
350
32-↑
Axial and
coronal
26/27
195/256
No
No
No
Yes
Dorsal with
phase
correction
2/1
No
No
Half-Fourier
Multiple
195/256
391
Yes
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formed by US, according to the previously
mentioned criteria of the Niamey protocol
adapted for MRI.
The observers had no previous informa-
tion on the sonographic classification.
The statistical analysis was based on the
calculation of the interobserver agreement
between MRI and the consensual gold stan-
dard obtained by sonographic evaluation.
RESULTS
The analysis of the MRI results by ob-
servers 1 and 2 demonstrated a global
interobserver agreement of 70% (14/20
patients) (Table 1).
A poor agreement was found in a com-
parison between MRI results analyzed by
the observer 1 and US results considered
as gold standard. Agreement was found in
only six cases (30%) (Figure 3), with dis-
crepancies in the classification of the 14
remaining patients (70%) (Table 2).
The results of the observer 2 were not
very different. Agreement was found only
in eight patients (40%) (Table 3).
The highest variation in the classifica-
tion level occurred with a patient classified
as level E at US and Levels A and C at MRI
(Figure 4).
The other differences occurred from a
classification level to its subsequent level,
i.e., D to E in two cases, and from E to F in
three cases (Figure 5).
DISCUSSION
Schistosomiasis is extremely important
both at national and international levels,
because of its high prevalence and morbid-
ity in patients at more advanced stages of
disease(2,10).
Generally, its treatment leads to a de-
crease in the levels of infection and im-
provement in some clinical findings such
as hepatosplenomegaly and periportal fi-
brosis. The reduction of periportal fibrosis
possibly prevents the emergence of portal
hypertension and may result event in de-
crease of the portal pressure(11), a fact that
highlights the significance of methods with
high reliability and reproducibility for the
disease follow-up.
Ultrasonography has been widely uti-
lized for evaluation of this disease, consid-
Table 1 Interobserver agreement in the evaluation of magnetic resonance imaging.
.
MRI2
A E F Total
n
1
–
–
–
1
%
5.0
–
–
–
5.0
C
D
E
F
n
–
2
1
–
3
%
–
10.0
5.0
–
15.0
n
–
–
3
13
16
%
–
–
15.0
65.0
80.0
n
1
2
4
13
20
%
5.0
10.0
20.0
65.0
100.0
MRI1
Total
MRI, magnetic resonance imaging; n, number of patients; A–F, fibrosis degrees according the Niamey qualitative
classification(5). Note: Agreeing cases in bold letters.
Table 2 Observer 1 results for magnetic resonance imaging reading.
US
E F Total
n
1
1
1
8
11
%
5.0
5.0
5.0
40.0
55.0
C
D
E
F
n
0
1
3
5
9
%
0.0
5.0
15.0
25.0
45.0
n
1
2
4
13
20
%
5.0
10.0
20.0
65.0
100.0
MRI
Total
US, ultrasound; MRI, magnetic resonance imaging; n, number of patients; A–F, fibrosis degrees according the
Niamey qualitative classification(5). Note: Agreeing cases in bold letters.
Figure 3. Ultrasound (A) and magnetic resonance imaging (B) of a patient with F scoring at both meth-
ods. Periportal fibrosis aspect (arrows).




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Table 3 Observer 2 results for magnetic resonance imaging reading.
US
E F Total
n
1
1
9
11
%
5.0
5.0
45.0
55.0
A
E
F
n
0
2
7
9
%
0.0
10.0
35.0
45.0
n
1
3
16
20
%
5.0
15.0
80.0
100.0
RM
Total
US, ultrasound; MRI, magnetic resonance imaging; n, number of patients; A, E, F, fibrosis degrees according the
Niamey qualitative classification(5). Note: Agreeing cases in bold letters.
ering its non-invasiveness, low cost and
wide availability, constituting the ideal
method for assessment of the disease in
large population groups.
This method can be utilized for detect-
ing portal fibrosis and hypertension (dila-
tation of portal and splenic veins and
portosystemic collaterals). Evidently, US is
more reliable than clinical methods for the
diagnosis of hepatosplenic diseases. Peri-
portal fibrosis, the essential lesion observed
in schistosomiasis, is generally identified
years after the infection onset, but it has
already been report at earlier stages of in-
festation(4). On the other hand, ultrasonog-
raphy has demonstrated just a moderate
reproducibility in the assessment of schis-
tosomal patients(6).
MRI, on its turn, has progressively
emerged as an extremely useful method in
the evaluation of focal or diffuse hepato-
pathies(12), and with the high reproducibil-
ity(13) necessary for consistent results,
stimulating the method adoption. Similarly,
MRI has demonstrated to be capable of
accurately identifying hepatic fibrosis(7,12).
Notwithstanding, until the present moment
there is no study in the literature compar-
ing the performances of MRI and US in the
evaluation of periportal fibrosis, so, as far
as we are concerned, the present study is
the first one to do it.
The portal fibrosis aspects have already
been described. On T1-weighted sequences,
fibrosis presents as a hypointense band in
relation to the liver, while on T2-weighted
sequences it presents a high signal(11), the
T2-weighted images being the most com-
prehensively utilized with this purpose ac-
cording to the literature(8,9,13,14), a fact ob-
served in the present study, although with
a poor agreement with sonographic find-
ings.
The present study presents some limi-
tations that must be pointed out. All of the
patients receive Niamey sonographic ref-
erence patterns E or F, characterizing an
advanced stage of periportal fibrosis and
limiting the evaluation of the method for
this group of patients. The method behav-
ior in the assessment of patients with
milder degrees of periportal fibrosis is still
to be known.
This also has prevented the kappa cal-
culation of interobserver agreement for
Figure 4. Ultrasound (A) and magnetic resonance imaging (B) of a patient with sonographic scoring E
and interobserver disagreement on magnetic resonance imaging readings (respectively scored as C and A).
Figure 5. Ultrasound (A) and magnetic resonance imaging (B) of a patient with sonographic scoring E,
and F at magnetic resonance imaging, with interobserver agreement on magnetic resonance imaging
readings. Periportal fibrosis aspect (arrows). Note the marked splenomegaly (star).
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MRI results because there was no patient
with all the levels of fibrosis according to
the Niamey criteria. On the other hand, the
patients who most benefited from a com-
prehensive assessment like that provided
by MRI, would be those with more ad-
vanced stages of the disease with higher
risks for developing complications. This
was precisely the group included in the
present study.
The adaptation of the Niamey ultra-
sonographic criteria to MRI demonstrated
a good reproducibility of the method
(70%), however, a satisfactory relation
between US and MRI classifications.
Agreement between both methods was
found in less than 50% of studied cases. A
possible explanation for this results may be
found in the subtle morphological variation
between E and F reference patterns, whose
the only difference is the parenchymal re-
traction in F, a finding that, like the others,
presents a certain subjectivity. It is impor-
tant to note that, even utilizing ultrasonog-
raphy, the interobserver variability is con-
siderable, which has been demonstrated in
another study developed by the authors(6).
Another factor to be considered is that the
present study is based on the assumptions
that US is the gold standard in the evalua-
tion of periportal fibrosis, despite the ab-
sence of a consensus on this matter. Cor-
relation between US, MRI and anatomo-
pathological analysis of periportal fibrosis
is still to be established to define which
method presents the higher efficacy.
Additional studies will be necessary to
establish a proposal of a simplified classi-
fication model for periportal fibrosis to
meet the needs of the professionals in-
volved in the follow-up of this group of
patients. Also studies involving a higher
number of patients in early stages of the
disease will be necessary to validate an
eventual MRI usefulness.
Finally, in the evaluation of periportal
fibrosis according to the criteria defined in
Niamey and adapted for MRI, the method
has presented a good reproducibility, but
low rate of agreement with US results, so
its applicability is still controversial, par-
ticularly in schistosomal patients.
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